us

BB Biotech AG BBAGF Stock

$55.00   -27.686670%
Add to favorites
Market Cap
$3.03B
LOW - HIGH [24H]
$33.65 - $33.65
VOLUME [24H]
$100.00
P/E Ratio
4.09
Earnings per share
$13.42
Price   Prediction

BB Biotech AG Price Chart

Sorry, that's all we've gotfor now...

BB Biotech AG BBAGF Financial and Trading Overview

BB Biotech AG stock price 55 USD
Previous Close 76.06 USD
Open 42.5 USD
Bid 66.62 USD x 10000
Ask 71.62 USD x 10000
Day's Range 33.65 - 33.65 USD
52 Week Range 33.65 - 76.06 USD
Volume 100 USD
Avg. Volume 0 USD
Market Cap 4.19B USD
Beta (5Y Monthly) 0.656
PE Ratio (TTM) 5.667504
EPS (TTM) 13.42 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date March 23, 2026
1y Target Est N/A

BBAGF Valuation Measures

Enterprise Value -120251200 USD
Trailing P/E 5.667504
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.9583566
Price/Book (mrq) 1.0895487
Enterprise Value/Revenue -0.113
Enterprise Value/EBITDA N/A

Trading Information

BB Biotech AG Stock Price History

Beta (5Y Monthly) 0.656
52-Week Change 0%
S&P500 52-Week Change 18.35%
52 Week High 76.06 USD
52 Week Low 33.65 USD
50-Day Moving Average 76.06 USD
200-Day Moving Average 76.06 USD

BBAGF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 55.15M
Float N/A
Short Ratio N/A
% Held by Insiders 0.077%
% Held by Institutions 19.24%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.25
Trailing Annual Dividend Yield 2.95%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 127.31%
Operating Margin (ttm) 97.74%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) 25.87%
Return on Equity (ttm) 54.76%

Income Statement

Revenue (ttm) 1.06B USD
Revenue Per Share (ttm) 19.24 USD
Quarterly Revenue Growth (yoy) 116257.69%
Gross Profit (ttm) 1.06B USD
EBITDA N/A
Net Income Avi to Common (ttm) 1.35B USD
Diluted EPS (ttm) 13.42
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.08B USD
Total Cash Per Share (mrq) 55.78 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 583.969
Book Value Per Share (mrq) 69.80679

Cash Flow Statement

Operating Cash Flow (ttm) 302.78M USD
Levered Free Cash Flow (ttm) 2.47B USD

Profile of BB Biotech AG

Country United States
State N/A
City Küsnacht
Address Seestrasse 16
ZIP CH-8700
Phone 41 44 2676700
Website https://www.bbbiotech.ch/en/bb-biotech/
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 10

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Q&A For BB Biotech AG Stock

What is a current BBAGF stock price?

BB Biotech AG BBAGF stock price today per share is 55 USD.

How to purchase BB Biotech AG stock?

You can buy BBAGF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BB Biotech AG?

The stock symbol or ticker of BB Biotech AG is BBAGF.

Which industry does the BB Biotech AG company belong to?

The BB Biotech AG industry is Biotechnology.

How many shares does BB Biotech AG have in circulation?

The max supply of BB Biotech AG shares is 55.15M.

What is BB Biotech AG Price to Earnings Ratio (PE Ratio)?

BB Biotech AG PE Ratio is 4.09836050 now.

What was BB Biotech AG earnings per share over the trailing 12 months (TTM)?

BB Biotech AG EPS is 13.42 USD over the trailing 12 months.

Which sector does the BB Biotech AG company belong to?

The BB Biotech AG sector is Healthcare.

$2.67T
Total marketcap
$88.26B
Total volume
BTC 59.25%     ETH 11.11%
Dominance
Select currency